![David Wilson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Wilson
Vorstandsvorsitzender bei
WG Partners LLP
Vermögen: 24 564 $ am 30.09.2026
Profil
Mr. David I.
Wilson is an Independent Non-Executive Director at Bionomics Ltd., a Chairman at WG Partners LLP and a Senior Board Advisor at Sapia Partners LLP.
He is on the Board of Directors at Neuphoria Therapeutics, Inc., CS Pharmaceuticals Ltd., Bionomics Ltd., Harris Academy Bromley and Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Mr. Wilson was previously employed as a Non-Executive Director by BerGenBio ASA, a Senior Independent Non-Executive Director by Optos Plc, a Deputy Chief Executive Officer by Matrix Corporate Capital LLP, a Joint Head-UK Investment Banking Group by ING Barings Group LLC, a Head-Small Companies Corporate Finance by Deutsche Bank AG /UK/, a Chief Executive Officer by Piper Jaffray Ltd., and a Head-Small Companies Corporate Broking by UBS AG (London Branch).
He received his undergraduate degree from the University of Cambridge.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0.13% | 17.09.2026 | 6’900 ( 0.13% ) | 24 564 $ | 30.09.2026 |
Aktive Positionen von David Wilson
| Unternehmen | Position | Beginn |
|---|---|---|
WG Partners LLP
 WG Partners LLP Investment Banks/BrokersFinance Provides brokerage services | Vorstandsvorsitzender | 01.10.2011 |
Harris Academy Bromley | Direktor/Vorstandsmitglied | - |
Sapia Partners LLP
 Sapia Partners LLP Investment ManagersFinance Sapia Partners invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Corporate Officer/Principal | - |
Bionomics Ltd.
 Bionomics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer and diseases of the central nervous system | Direktor/Vorstandsmitglied | 16.06.2016 |
CS Pharmaceuticals Ltd. | Direktor/Vorstandsmitglied | 01.07.2021 |
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
 Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops ocular therapeutics and treatments for rare diseases | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von David Wilson
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOINVENT ASA | Direktor/Vorstandsmitglied | 01.01.2016 |
Matrix Corporate Capital LLP
 Matrix Corporate Capital LLP Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01.10.2011 |
Piper Sandler Ltd.
 Piper Sandler Ltd. Investment Banks/BrokersFinance Provides brokerage services | Vorstandsvorsitzender | 01.01.2011 |
| ░░░ ░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ ░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von David Wilson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Deutsche Bank AG /UK/
 Deutsche Bank AG /UK/ Investment Banks/BrokersFinance Deutsche Bank UK is an active manager which constructs tailored investment strategies in line with their clients' risk/reward profile for a variety of strategies including aggressive growth, growth, income or security. They construct portfolios comprised of asset classes such as bonds, equities, alternative investments and foreign exchange. The firm bases their investment decisions on the group's worldwide network of experts, in addition to their regional and local expertise. | Finance |
Piper Sandler Ltd.
Piper Sandler Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer and diseases of the central nervous system | Health Technology |
ING Barings Group LLC
 ING Barings Group LLC Investment Banks/BrokersFinance Provides investment banking and financial services | Finance |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optos Plc
 Optos Plc Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets retinal imaging devices | Health Technology |
UBS AG (London Branch)
 UBS AG (London Branch) Investment ManagersFinance Provides wealth, asset management and investment banking services | Finance |
Matrix Corporate Capital LLP
Matrix Corporate Capital LLP Investment Banks/BrokersFinance Provides brokerage services | Finance |
BerGenBio ASA
 BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Sapia Partners LLP
Sapia Partners LLP Investment ManagersFinance Sapia Partners invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
WG Partners LLP
WG Partners LLP Investment Banks/BrokersFinance Provides brokerage services | Finance |
Harris Academy Bromley | |
CS Pharmaceuticals Ltd. | |
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops ocular therapeutics and treatments for rare diseases | Commercial Services |
